Arab Region | Proportion of the target population with access to pneumococcal conjugate third dose PCV3 (Arab countries, 2008–2021)
Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the recommended doses of pneumococcal conjugate vaccine.
Arab Region | Proportion of the target population with access to pneumococcal conjugate third dose PCV3 (Arab countries, 2008–2021)
| Location | Year | value |
|---|---|---|
| Algeria | 2016 | 61 |
| Algeria | 2017 | 89 |
| Algeria | 2018 | 91 |
| Algeria | 2019 | 91 |
| Algeria | 2020 | 91 |
| Algeria | 2021 | 91 |
| Djibouti | 2013 | 82 |
| Djibouti | 2014 | 78 |
| Djibouti | 2015 | 82 |
| Djibouti | 2016 | 68 |
| Djibouti | 2017 | 76 |
| Djibouti | 2018 | 84 |
| Djibouti | 2019 | 85 |
| Djibouti | 2020 | 70 |
| Djibouti | 2021 | 59 |
| Bahrain | 2008 | 14 |
| Bahrain | 2009 | 96 |
| Bahrain | 2010 | 99 |
| Bahrain | 2011 | 99 |
| Bahrain | 2012 | 99 |
| Bahrain | 2013 | 99 |
| Bahrain | 2014 | 98 |
| Bahrain | 2015 | 98 |
| Bahrain | 2016 | 99 |
| Bahrain | 2017 | 97 |
| Bahrain | 2018 | 98 |
| Bahrain | 2019 | 97 |
| Bahrain | 2020 | 99 |
| Bahrain | 2021 | 99 |
| Iraq | 2017 | 33 |
| Iraq | 2018 | 33 |
| Iraq | 2019 | 37 |
| Iraq | 2020 | 0 |
| Iraq | 2021 | 0 |
| Kuwait | 2008 | 99 |
| Kuwait | 2009 | 99 |
| Kuwait | 2010 | 98 |
| Kuwait | 2011 | 99 |
| Kuwait | 2012 | 99 |
| Kuwait | 2013 | 99 |
| Kuwait | 2014 | 94 |
| Kuwait | 2015 | 99 |
| Kuwait | 2016 | 99 |
| Kuwait | 2017 | 99 |
| Kuwait | 2018 | 91 |
| Kuwait | 2019 | 93 |
| Kuwait | 2020 | 94 |
| Kuwait | 2021 | 96 |
| Lebanon | 2017 | 82 |
| Lebanon | 2018 | 82 |
| Lebanon | 2019 | 82 |
| Lebanon | 2020 | 74 |
| Lebanon | 2021 | 70 |
| Libya | 2014 | 39 |
| Libya | 2015 | 71 |
| Libya | 2016 | 96 |
| Libya | 2017 | 94 |
| Libya | 2018 | 72 |
| Libya | 2019 | 73 |
| Libya | 2020 | 73 |
| Libya | 2021 | 73 |
| Mauritania | 2013 | 1 |
| Mauritania | 2014 | 71 |
| Mauritania | 2015 | 71 |
| Mauritania | 2016 | 71 |
| Mauritania | 2017 | 72 |
| Mauritania | 2018 | 72 |
| Mauritania | 2019 | 76 |
| Mauritania | 2020 | 70 |
| Mauritania | 2021 | 65 |
| Morocco | 2010 | 1 |
| Morocco | 2011 | 23 |
| Morocco | 2012 | 72 |
| Morocco | 2013 | 80 |
| Morocco | 2014 | 90 |
| Morocco | 2015 | 95 |
| Morocco | 2016 | 98 |
| Morocco | 2017 | 99 |
| Morocco | 2018 | 99 |
| Morocco | 2019 | 98 |
| Morocco | 2020 | 98 |
| Morocco | 2021 | 98 |
| Oman | 2009 | 96 |
| Oman | 2010 | 99 |
| Oman | 2011 | 99 |
| Oman | 2012 | 99 |
| Oman | 2013 | 99 |
| Oman | 2014 | 98 |
| Oman | 2015 | 98 |
| Oman | 2016 | 99 |
| Oman | 2017 | 99 |
| Oman | 2018 | 99 |
| Oman | 2019 | 99 |
| Oman | 2020 | 99 |
| Oman | 2021 | 99 |
| Qatar | 2009 | 99 |
| Qatar | 2010 | 97 |
| Qatar | 2011 | 98 |
| Qatar | 2012 | 92 |
| Qatar | 2013 | 99 |
Arab Region | Proportion of the target population with access to pneumococcal conjugate third dose PCV3 (Arab countries, 2008–2021)
Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the recommended doses of pneumococcal conjugate vaccine.